SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced an agreement for global distribution of Cartagenia’s cloud-based software for copy number variation (CNV) analysis. This agreement will enable Agilent to sell usage-priced annual licenses for Cartagenia’s Bench Lab CNV module to small and medium-sized cytogenetic laboratories. The use-based licenses allow labs with limited [...]

The new WITec Suite software is now available for all WITec imaging systems. It was specifically developed to acquire and process large data volumes of large-area, high-resolution measurements and 3D imaging while providing speed, performance, and usability. Through the software architecture and graphical user interface an integrated and consolidated functionality is available incorporating the various [...]

Hercules, CA — — Bio-Rad Laboratories, Inc. announces the launch the new and improved Precision Plus Protein™ Dual Color Standards, the brightest protein marker available. The strong marker persistence of the Precision Plus Protein Dual Color Standards throughout electrophoresis and western blotting, even during rigorous stripping and reprobing protocols, makes the product a more effective [...]

OMAHA, Neb.-- Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that it has signed a license with the Dana-Farber Cancer Institute for worldwide rights to develop and commercialize multiplexed versions of its ICE COLD-PCRTM technology [...]

Basel, Switzerland -- Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that Biopharm R&D at GlaxoSmithKline (GSK) has selected Genedata BiologicsTM as a key R&D data management and workflow-support platform. The Genedata Biologics platform will support multiple GSK Biopharm R&D groups including lead identification and screening, [...]

ALAMEDA, Calif. -- BioTime, Inc. (NYSE MKT: BTX) today announced that it has received ISO 13485:2003 certification from BSI (British Standards Institution) for design, development, manufacture, and distribution of BioTime HyStem® hydrogels for cell delivery applications. BSI is currently one of the world’s largest independent certification bodies for quality management systems and ISO 13485:2003 is [...]

WALLDORF — SAP AG today announced a strategic collaboration with Stanford School of Medicine to research the contribution of genetics, environmental exposures, behavior and other factors to disease susceptibility using the power of the SAP HANA platform. The company also announced its participation in the Global Alliance for Genomics and Health, a council of industry [...]

France -- The General Meeting of Shareholders of bioMérieux, a world leader in the field of in vitro diagnostics, today approved the appointment of two new independent directors, Agnès Lemarchand and Philippe Gillet. Agnès Lemarchand and Philippe Gillet were appointed to replace Georges Hibon and Michel Angé, who did not wish to renew their terms [...]

Schlieren, Switzerland -- InSphero AG today announced the launch of 3D InSight™ Human and Rat Pancreatic Microislets, further expanding the company’s catalog of organotypic 3D models produced using their patented hanging-drop production technology. The product launch follows InSphero‘s April publication of the microislets in theJournal of Tissue Engineering and Regenerative Medicine, characterizing their physiological properties [...]

MENLO PARK, Calif. & ALAMEDA, Calif.-- BioTime, Inc. (NYSE MKT: BTX) and its subsidiary Asterias Biotherapeutics, Inc. (“Asterias”), announced that Asterias has entered into a settlement agreement with ViaCyte, Inc. (“ViaCyte”) concerning certain litigation in the United States District Court for the Northern District of California (Civil Action No. C12-04813) seeking the reversal of two [...]